Public health leader from RTI International named to American Diabetes Association National Board of Directors

January 10, 2019

RESEARCH TRIANGLE PARK, NC—Dr. Jean C. O’Connor, a senior public health practitioner with RTI International (RTI), a nonprofit research institute, has been named an at-large member of the American Diabetes Association (ADA) National Board of Directors. The ADA welcomed new members of the board in an announcement on Tuesday.

The 18-member board is comprised of forward-thinking medical, scientific, education and executive professionals. The board strategically leads and focus efforts of the ADA, a U.S.-based nonprofit that aims to prevent and cure diabetes, as well as improve the lives of all people affected by the disease.

O’Connor, who has nearly two decades of experience as a public health leader, is an expert in non-communicable diseases and population health improvement, and the design and evaluation of policies that influence health outcomes.

In addition to her work at RTI, O’Connor is an Adjunct Associate Professor at the Rollins School of Public Health at Emory, on the editorial board for a peer-reviewed medical journal called Preventing Chronic Disease and a past-president of the National Association of Chronic Disease Directors. She is also a member of the State Bar of Georgia and a Fellow in the American College of Healthcare Executives.

RTI International Non-Communicable Diseases Work 

RTI is working with global partners and country leaders to design, implement, and evaluate policy, prevention, and treatment interventions and long-term solutions. Together, we are helping country-level partners to reduce premature mortality from non-communicable diseases (NCDs), supporting the achievement of universal health coverage, strengthening health systems and responses to reduce harmful use of alcohol and tobacco, and improving access to essential medicines and treatments.

RTI has accumulated 60 years of expertise in research, policy analysis and development, health economics and financing, on-the-ground project implementation, and health systems strengthening. Along the way, RTI has become an integral partner in both assessing and successfully addressing the negative health, economic, and social impacts of NCDs. For more information about how we are addressing the burden of NCDs globally, visit